Leniolisib phosphateProduct ingredient for Leniolisib

Name
Leniolisib phosphate
Drug Entry
Leniolisib

Leniolisib is a potent and selective inhibitor of phosphoinositide 3-kinase δ (PI3Kδ). The FDA approved leniolisib on March 24, 2023, making it the first treatment for activated phosphoinositide 3-kinase delta syndrome (APDS).10 APDS is a primary immunodeficiency caused by mutations in genes encoding the PI3Kδ, thereby increasing the activity of PI3Kδ, causing immune dysfunction, and elevating susceptibility to infections.1,2 Leniolisib works to inhibit hyperactive PI3Kδ.9 Investigations for using leniolisib in primary Sjögren’s syndrome are ongoing.3

Accession Number
DBSALT003336
Structure
Synonyms
Not Available
UNII
3700M1H39Q
CAS Number
1354691-97-6
Weight
Average: 548.46
Monoisotopic: 548.176004133
Chemical Formula
C21H28F3N6O6P
InChI Key
XXEDEGOAYSGNPS-ZOWNYOTGSA-N
InChI
InChI=1S/C21H25F3N6O2.H3O4P/c1-3-18(31)30-6-4-13(10-30)28-19-15-11-29(7-5-17(15)26-12-27-19)14-8-16(21(22,23)24)20(32-2)25-9-14;1-5(2,3)4/h8-9,12-13H,3-7,10-11H2,1-2H3,(H,26,27,28);(H3,1,2,3,4)/t13-;/m0./s1
IUPAC Name
1-[(3S)-3-({6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-4-yl}amino)pyrrolidin-1-yl]propan-1-one; phosphoric acid
SMILES
OP(O)(O)=O.CCC(=O)N1CC[C@@H](C1)NC1=C2CN(CCC2=NC=N1)C1=CN=C(OC)C(=C1)C(F)(F)F
ChemSpider
52083075
ChEMBL
CHEMBL3989909
Wikipedia
Leniolisib
Predicted Properties
PropertyValueSource
logP2.01Chemaxon
pKa (Strongest Acidic)18.21Chemaxon
pKa (Strongest Basic)5.43Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count7Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area83.48 Å2Chemaxon
Rotatable Bond Count6Chemaxon
Refractivity115.08 m3·mol-1Chemaxon
Polarizability44.76 Å3Chemaxon
Number of Rings4Chemaxon
Bioavailability1Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleYesChemaxon